scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1021148732 |
P356 | DOI | 10.1007/S00213-015-4050-7 |
P698 | PubMed publication ID | 26297326 |
P50 | author | Jordan M Ward | Q85948162 |
P2093 | author name string | Benjamin F Cravatt | |
Cheryl L Limebeer | |||
Linda A Parker | |||
Micah J Niphakis | |||
Erin M Rock | |||
Katherine Grove | |||
Arianne Cohen | |||
P2860 | cites work | Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-alpha | Q24319974 |
Discovery and Characterization of a Highly Selective FAAH Inhibitor that Reduces Inflammatory Pain | Q27655121 | ||
Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist | Q28262546 | ||
Inhibition of FAAH and activation of PPAR: new approaches to the treatment of cognitive dysfunction and drug addiction | Q28283718 | ||
Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors | Q28292914 | ||
Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides | Q28295481 | ||
Regulation of nausea and vomiting by cannabinoids and the endocannabinoid system | Q28301264 | ||
Inhibition of peroxisome-proliferator-activated receptor (PPAR)alpha by MK886 | Q28366307 | ||
Targeted enhancement of oleoylethanolamide production in proximal small intestine induces across-meal satiety in rats | Q28581609 | ||
Isolation and structure of a brain constituent that binds to the cannabinoid receptor | Q29547476 | ||
Modulation of anxiety through blockade of anandamide hydrolysis | Q29615902 | ||
The nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the anti-inflammatory actions of palmitoylethanolamide. | Q33844609 | ||
SR141716A, a potent and selective antagonist of the brain cannabinoid receptor | Q34332716 | ||
A role for monoglyceride lipase in 2-arachidonoylglycerol inactivation | Q35035844 | ||
Endogenous fatty acid ethanolamides suppress nicotine-induced activation of mesolimbic dopamine neurons through nuclear receptors | Q35202878 | ||
Chronic stimulation of the tone of endogenous anandamide reduces cue- and stress-induced relapse in rats | Q35203593 | ||
Anticipatory nausea and vomiting. | Q35984598 | ||
Characterization of the effects of reuptake and hydrolysis inhibition on interstitial endocannabinoid levels in the brain: an in vivo microdialysis study | Q36056312 | ||
Nausea: the neglected symptom? | Q36073306 | ||
Chemotherapy-induced nausea and vomiting: prevention, detection, and treatment--how are we doing? | Q36238290 | ||
Endocannabinoid regulation of nausea is mediated by 2-arachidonoylglycerol (2-AG) in the rat visceral insular cortex | Q36421863 | ||
Patient perceptions of the side-effects of chemotherapy: the influence of 5HT3 antagonists | Q36431212 | ||
Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics follo | Q36476481 | ||
Fatty acid amide hydrolase (FAAH) inhibition enhances memory acquisition through activation of PPAR-alpha nuclear receptors. | Q37194497 | ||
Fat-induced satiety factor oleoylethanolamide enhances memory consolidation. | Q37194726 | ||
Fatty acid amide hydrolase (FAAH) knockout mice exhibit enhanced acquisition of an aversive, but not of an appetitive, Barnes maze task | Q37346278 | ||
Current pharmacotherapy for chemotherapy-induced nausea and vomiting in cancer patients | Q37609798 | ||
A review of granisetron, 5-hydroxytryptamine3 receptor antagonists, and other antiemetics | Q37789126 | ||
Conditioned flavor avoidance and conditioned gaping: rat models of conditioned nausea | Q38155381 | ||
Anticipatory nausea in animal models: a review of potential novel therapeutic treatments | Q38208999 | ||
The 5-lipoxygenase-activating protein (FLAP) inhibitor, MK886, induces apoptosis independently of FLAP. | Q38324576 | ||
On the receiving end. V: Patient perceptions of the side effects of cancer chemotherapy in 1993. | Q39428685 | ||
Rewarding drugs produce taste avoidance, but not taste aversion | Q40538682 | ||
Progress in reducing nausea and emesis. Comparisons of ondansetron (Zofran), granisetron (Kytril), and tropisetron (Navoban). | Q40984061 | ||
Inverse agonism of cannabinoid CB1 receptors potentiates LiCl‐induced nausea in the conditioned gaping model in rats | Q41682319 | ||
Evaluation of the potential of the phytocannabinoids, cannabidivarin (CBDV) and Δ(9) -tetrahydrocannabivarin (THCV), to produce CB1 receptor inverse agonism symptoms of nausea in rats | Q41907106 | ||
Emetic action of the prostanoid TP receptor agonist, U46619, in Suncus murinus (house musk shrew). | Q44683171 | ||
Inhibition of fatty-acid amide hydrolase accelerates acquisition and extinction rates in a spatial memory task | Q44924131 | ||
Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3'-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation. | Q45173372 | ||
A quantitative comparison of taste reactivity behaviors to sucrose before and after lithium chloride pairings: a unidimensional account of palatability | Q45940780 | ||
The effect of cannabidiol and URB597 on conditioned gaping (a model of nausea) elicited by a lithium-paired context in the rat. | Q46907848 | ||
Anticipatory nausea and vomiting in the era of 5-HT3 antiemetics | Q47965336 | ||
Intra-visceral insular cortex 2-arachidonoylglycerol, but not N-arachidonoylethanolamide, suppresses acute nausea-induced conditioned gaping in rats | Q48415308 | ||
Effect of selective inhibition of monoacylglycerol lipase (MAGL) on acute nausea, anticipatory nausea, and vomiting in rats and Suncus murinus | Q48624095 | ||
Effect of chronic exposure to rimonabant and phytocannabinoids on anxiety-like behavior and saccharin palatability. | Q50551336 | ||
Effects of the FAAH inhibitor, URB597, and anandamide on lithium-induced taste reactivity responses: a measure of nausea in the rat. | Q52001605 | ||
The antiemetic drug ondansetron interferes with lithium-induced conditioned rejection reactions, but not lithium-induced taste avoidance in rats. | Q52163535 | ||
Chemotherapy-Induced Nausea and Vomiting | Q56657991 | ||
Progress in reducing anticipatory nausea and vomiting: a study of community practice | Q74152739 | ||
Synthesis, structure-activity, and structure-stability relationships of 2-substituted-N-(4-oxo-3-oxetanyl) N-acylethanolamine acid amidase (NAAA) inhibitors | Q87057318 | ||
P433 | issue | 20 | |
P921 | main subject | niacinamide | Q192423 |
P1104 | number of pages | 8 | |
P304 | page(s) | 3841-3848 | |
P577 | publication date | 2015-08-23 | |
P1433 | published in | Psychopharmacology | Q1422802 |
P1476 | title | Interference with acute nausea and anticipatory nausea in rats by fatty acid amide hydrolase (FAAH) inhibition through a PPARα and CB1 receptor mechanism, respectively: a double dissociation | |
P478 | volume | 232 |
Q41155213 | A comparison of novel, selective fatty acid amide hydrolase (FAAH), monoacyglycerol lipase (MAGL) or dual FAAH/MAGL inhibitors to suppress acute and anticipatory nausea in rat models |
Q38808034 | An update on PPAR activation by cannabinoids. |
Q87958145 | Anticonvulsive effects of endocannabinoids; an investigation to determine the role of regulatory components of endocannabinoid metabolism in the Pentylenetetrazol induced tonic- clonic seizures |
Q38598515 | Cannabinoid Regulation of Acute and Anticipatory Nausea |
Q26738288 | Cannabinoids As Potential Treatment for Chemotherapy-Induced Nausea and Vomiting |
Q39027559 | Elevation of 2-AG by monoacylglycerol lipase inhibition in the visceral insular cortex interferes with anticipatory nausea in a rat model |
Q36421863 | Endocannabinoid regulation of nausea is mediated by 2-arachidonoylglycerol (2-AG) in the rat visceral insular cortex |
Q90727616 | Nausea-Induced 5-HT Release in the Interoceptive Insular Cortex and Regulation by Monoacylglycerol Lipase (MAGL) Inhibition and Cannabidiol |
Q45930672 | Suppression of acute and anticipatory nausea by peripherally restricted fatty acid amide hydrolase inhibitor in animal models: role of PPARα and CB1 receptors. |
Search more.